MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-17-2026
ClearPoint Neuro Cash and Cash Equivalents 2011-2026 | CLPT
Annual Cash and Cash Equivalents ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.9 M | 20.1 M | 23.1 M | 27.6 M | 54.1 M | 20.1 M | 5.7 M | 3.1 M | 9.29 M | 3.32 M | 5.41 M | 9.24 M | 3.52 M | 1.62 M | 145 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.1 M | 145 K | 15.5 M |
Quarterly Cash and Cash Equivalents ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.2 M | 41.5 M | 12.4 M | 20.1 M | 21.6 M | 32.8 M | 35.4 M | 23.1 M | 24.3 M | 26.5 M | 21.8 M | 27.6 M | 18.7 M | 23.5 M | 49.7 M | 54.1 M | 57.7 M | 61.5 M | 64.9 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 3.32 M | 3.32 M | 3.32 M | 3.32 M | 5.41 M | 5.41 M | 5.41 M | 5.41 M | 9.24 M | 9.24 M | 9.24 M | 9.24 M | 3.52 M | 3.52 M | 3.52 M | 3.52 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 145 K | 145 K | 145 K | 145 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 64.9 M | 145 K | 15.3 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
35.5 M | $ 32.25 | -3.09 % | $ 1.49 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.01 | -6.94 % | $ 1.22 M | USA |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 9.38 | -1.78 % | $ 722 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Inogen
INGN
|
104 M | $ 6.5 | 1.25 % | $ 173 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.35 | 1.89 % | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
51.2 M | $ 98.74 | -2.99 % | $ 1.26 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
LENSAR
LNSR
|
16.3 M | $ 5.52 | -1.08 % | $ 63.6 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.13 | -0.76 % | $ 327 M | USA |
 |
Medtronic PLC
MDT
|
2.22 B | $ 87.67 | -0.24 % | $ 113 B | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Orthofix Medical
OFIX
|
82 M | $ 11.79 | -1.17 % | $ 467 M |  Curacao |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
Outset Medical
OM
|
35 M | $ 3.52 | -0.28 % | $ 53.5 K | USA |
 |
PAVmed
PAVM
|
19.6 M | $ 8.94 | -3.87 % | $ 64.7 M | USA |
 |
Insulet Corporation
PODD
|
716 M | $ 218.11 | 0.98 % | $ 15.3 B | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 36.64 | -1.05 % | $ 1.14 B | USA |
 |
Quanterix Corporation
QTRX
|
29.8 M | $ 3.9 | -1.52 % | $ 166 M | USA |
 |
Electromed
ELMD
|
15.3 M | $ 24.45 | -0.85 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
4.14 M | $ 2.42 | -5.47 % | $ 6.71 M | USA |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.6 | -10.61 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.27 | -2.16 % | $ 3.54 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
Sensus Healthcare
SRTS
|
22.1 M | $ 4.01 | -4.98 % | $ 65.5 M | USA |
 |
LivaNova PLC
LIVN
|
636 M | $ 63.65 | 0.55 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
8.94 M | $ 1.73 | -1.14 % | $ 111 M |  Israel |
 |
Stryker Corporation
SYK
|
4.01 B | $ 332.68 | 1.57 % | $ 127 B | USA |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 11.41 | 0.18 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
187 M | $ 336.42 | 0.04 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
166 M | $ 3.94 | -3.9 % | $ 582 M | USA |
 |
Tandem Diabetes Care
TNDM
|
90.6 M | $ 23.32 | -3.87 % | $ 1.59 B | USA |